European patient survey finds crohn's disease patients living with perianal fistulas experience a more significant negative impact on their quality of life than crohn's disease patients without perianal fistulas

Zurich & brussels--(business wire)--the european federation of crohn's and ulcerative colitis associations (“efcca”) in collaboration with takeda pharmaceutical company limited (“takeda”) today announced results from one of the largest of its kind self-reported patient surveys, exploring the health-related and overall real-world impact of perianal fistulas on the quality of life of people with crohn's disease (cd), compared to the impact of cd without perianal fistulas.1,2,3,4,5,6 the survey fo
TAK Ratings Summary
TAK Quant Ranking